Search Results - "Tran Cao, H.S."

The Battle Of The Sexes: Women Win Out In Gastrointestinal Surgery by Peterson, C.Y, Osen, H.B, Tran Cao, H.S, Yu, P.T, Chang, D.C

Get full text

Abstract P1-02-01: HER2/neu antibody-fluorophore conjugate for intraoperative detection of HER2-positive breast cancer by Simien, Jo, Voss, Julie, Thompson, A.M., Ghosh, S.C., AghaAmiri, S., Azhdarinia, A., Tran-Cao, H.S.

“…Abstract Background: Although advances in neoadjuvant and adjuvant treatments have led to enhanced survival in patients with HER2 positive breast cancer,…”
Get full text

Revisiting the malignant masquerade at the liver hilum: have we made progress? by Jain, A.J., Lendoire, M., Boyev, A., Newhook, T.E., Tzeng, C.W., Tran Cao, H.S., Vauthey, J.N., Chun, Y.S.

Get full text

Parenchymal-sparing hepatectomy is associated with a higher rate of positive margins than single-stage major hepatectomy but not higher recurrence rate in patients with five or more bilateral colorectal liver metastases by Lendoire, M., Maki, H., Haddad, A., Cao, H.S. Tran, Chun, Y.S., Tzeng, C.-W.D., Vauthey, J.-N., Newhook, T.E.

Get full text

973P Clinicopathologic and treatment outcome data in 165 fibrolamellar carcinoma patients by Lee, S., Chamseddine, S., R. hiatia, Hu, Z.I., Mahvash, A., Vauthey, J.N., Tran Cao, H.S., Chun, Y.S., Tzeng, C-W.D., Newhook, T., Ludmir, E.B., Habibollahi, P., Metwalli, Z., Kaseb, A.

Get full text

Tips and tricks for robotic hepatectomy: Inflow control and exposure by Newhook, T.E., Jain, A., Lilley, E., Ikoma, N., Maxwell, J., Tzeng, C.D., Chun, Y.S., Vauthey, J.N., Tran Cao, H.S.

Get full text

A Biology-Driven Radiomics Model for Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiotherapy by De, B., Zaid, M., Sun, K., Van Wieren, A., Kumala, T., Minsky, B.D., Smith, G.L., Holliday, E., Taniguchi, C.M., Koong, A.C., Das, P., Cao, H.S. Tran, Lee, S., Vauthey, J.N., Javle, M., Ludmir, E.B., Koay, E.J.

Get full text

Survival improvement over time in patients with young-onset colorectal cancer with resected synchronous liver metastases by Haddad, A., Lendoire, M., Maki, H., Tzeng, C.W.D., Tran Cao, H.S., Chun, Y.S., Peacock, O., Bednarski, B.K., Konishi, T., Vauthey, J.N., You, Y.N., Newhook, T.E.

Get full text

Exceptional pathologic response to preoperative therapy in the context of mutational profiling for colorectal liver metastases by Lendoire, M., Maki, H., Haddad, A., Panettieri, E., Chun, Y.S., Tzeng, C.-W.D., Newhook, T.E., Vauthey, J.-N., Cao, H.S. Tran

Get full text

Survival gains in patients with young-onset colorectal cancer and synchronous liver metastases by Lendoire, M., Maki, H., Haddad, A., Tzeng, C.W., Tran Cao, H.S., Chun, Y.S., Peacock, O., Bednarski, B.K., Konishi, T., Vauthey, J.N., You, Y.N., Newhook, T.E.

Get full text

Is There a Role for Surgery in T2 and T3 Hepatocellular Carcinoma? A Propensity-matched Analysis of the National Cancer Database by Kothari, A.N., Tzeng, C.W., Aloia, T.A., Chun, Y.S., Vauthey, J.N., Cao, H.S. Tran

Get full text

Molecular Profiling May Predict Colorectal Liver Metastases at Greatest Risk for Disappearing after Chemotherapy by DiBrito, S., Martin, A., Nishioka, Y., Newhook, T., Chun, Y.S., Tzeng, C.W., Vauthey, J.-N., Cao, H.S. Tran

Get full text

Neoadjuvant Chemotherapy for High-risk Intrahepatic Cholangiocarcinoma – Does Pathologic Response Mean Better Outcomes? by Arango, N. Paez, Ayabe, R., Jeannelyn, E., Newhook, T., Tzeng, C.-W.D., Chun, Y.S., Lee, S., Javle, M., Vauthey, J.-N., Cao, H.S. Tran

Get full text

Individual Components of Post-Hepatectomy Care Pathways Have Differential Impacts on Length of Stay by Martin, A.N., Kim, B.J., Newhook, T.E., Arvide, E.M., Dewhurst, W.L., Kawaguchi, Y., Cao, H.S. Tran, Chun, Y.S., Katz, M.H., Vauthey, J.-N., Tzeng, C.-W.D.

Get full text

An Imaging Feature From Pre-Therapy Computed Tomography (CT) Scans Correlates With Pathological and the Clinical Outcomes in Patients (Pts) With Intrahepatic Cholangiocarcinoma (iCCA) by Zaid, M., Carapeto, F., Dai, A., Thunshelle, C.P., Elganainy, D., Sun, K., Grassberger, C., Kwong, L.N., Lee, S., Newhook, T., Tran Cao, H.S., Vauthey, J.N., Javle, M., Koay, E.J.

“…Intrahepatic cholangiocarcinoma (iCCA) remains a highly lethal disease. Biomarkers are needed to identify pts who may benefit from specific therapeutic…”
Get full text

LBA47 - Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC by Kaseb, A., Duda, D.G., Tran Cao, H.S., Abugabal, Y.I., Vence, L.M., Rashid, A., Carmagnani Pestana, R., Blando, J.M., Singh, S., Vauthey, J.N., Chun, Y.S., Tzeng, C-W D, Sakamuri, D., Wolff, R.A., Yao, J.C., Allison, J., Sharma, P.

“…In HCC, surgical resection is associated with high recurrence rates, and no effective neoadjuvant or adjuvant therapies currently exist. Immunotherapy using…”
Get full text

Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC by Kaseb, A., Duda, D.G., Tran Cao, H.S., Abugabal, Y.I., Vence, L.M., Rashid, A., Carmagnani Pestana, R., Blando, J.M., Singh, S., Vauthey, J.N., Chun, Y.S., Tzeng, C-W D, Sakamuri, D., Wolff, R.A., Yao, J.C., Allison, J., Sharma, P.

Get full text

Cystic hepatic lesions: No one imaging feature to rule them all by Day, R.W., Kang, C.H., Aloia, T.A., Vauthey, J.N., Tzeng, C.D., Tran Cao, H.S., Kaur, H., Chun, Y.S.

Get full text

Impact of recent guidelines on overtreatment of asymptomatic pancreatic cystic lesions by Baugh, K.A., Tran Cao, H.S., Van Buren, G., Silberfein, E.J., Hsu, C., Barakat, O., Massarweh, N.N., Fisher, W.E.

Get full text

143P Genomic characterization and outcomes of patients with primary sclerosing cholangitis-related cholangiocarcinoma by Haro-Silerio, J.I., Lee, S., Bhamidipati, D., Fox, D.A., Koay, E., Ludmir, E., Chatterjee, D., Javle, M., Pant, S., Hu, Z.I., Tzeng, C-W.D., Chun, Y.S., Cao, H.S. Tran, Newhook, T., Vauthey, J.N., Connor, A.A., Sudha, K., Abdelrahim, M., Cox, V., Kang, H.

Get full text